Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia

Prijo Sidipratomo; Jacub Pandelaki; Sahat B R E Matondang; Heltara Ramandika; Rita Sita Sitorus; Komang S Karismaputri; Anindyagari

doi:10.1016/j.radcr.2022.09.004

Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia

Radiol Case Rep. 2022 Oct 2;17(12):4713-4716. doi: 10.1016/j.radcr.2022.09.004. eCollection 2022 Dec.

Authors

Prijo Sidipratomo¹, Jacub Pandelaki¹, Sahat B R E Matondang¹, Heltara Ramandika¹, Rita Sita Sitorus², Komang S Karismaputri¹, Anindyagari¹

Affiliations

¹ Department of Radiology, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jl. Pangeran Diponegoro No. 71, Central Jakarta 10430, Indonesia.
² Department of Ophthalmology, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jl. Pangeran Diponegoro No. 71, Central Jakarta 10430, Indonesia.

Abstract

Intra-arterial chemotherapy (IAC) has become the mainstay therapy for retinoblastoma group D and E for the past few decades. However, IAC had never been done in Indonesia before. In this report, we present a case of a 2-year-old girl with recurrent Group D retinoblastoma of the left eye that improved significantly after one session of IAC, the first IAC in Indonesia.

Keywords: Intra-arterial chemotherapy; Melphalan; Retinoblastoma.

Publication types

Case Reports